A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Ziresovir in Healthy Subjects
Clinical trial NCT04788017 · COMPLETED
Trial details
- NCT number
- NCT04788017
- Sponsor
- Shanghai Ark Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-24
- Primary completion
- 2021-06-14
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.